A Form 4 filed on August 17, 2026, disclosed that Karni Yarl Andorn, a director of Camtek Ltd (NASDAQ:CAMT), exercised stock options and sold ordinary shares on August 13 and August 14, 2026.

Key Highlights

  • Option exercise on Aug. 13: The director acquired 880 ordinary shares via stock option exercise at $63.51 per share.
  • Sales on Aug. 13: 880 shares were sold at $172.7428 and 1,476 shares were sold at a weighted average price of $172.1221 (ranging from $172.1094 to $172.1571).
  • Option exercise on Aug. 14: 3,176 ordinary shares were acquired via stock option exercise at $22.63 per share.
  • Sale on Aug. 14: 3,176 shares were sold at $164.40 per share.
  • Remaining ownership: Following all reported transactions, the director directly owned 1,343 ordinary shares.
  • Expiring options fully exercised: Both option tranches were reduced to zero following the reported exercises.

Camtek Director's Two-Day Option Exercise and Share Sale Activity

According to the filing, Andorn Karni Yarl, identified as a director of Camtek Ltd, executed a series of transactions across two consecutive trading days. On August 13, 2026, the director exercised a stock option with an exercise price of $63.51 to acquire 880 ordinary shares, then sold those 880 shares at $172.7428 per share. On the same date, an additional 1,476 shares were sold at a weighted average price of $172.1221. The filing notes that this weighted average reflects multiple transactions ranging from $172.1094 to $172.1571, and states that full per-transaction detail will be provided upon request.

On August 14, 2026, the director exercised a second stock option, this one carrying an exercise price of $22.63, acquiring 3,176 ordinary shares. Those shares were then sold the same day at $164.40 per share. The filing confirms that in both cases the options were exercised and the underlying shares were sold on the same date. Both option tranches, one expiring December 21, 2030 and the other expiring November 10, 2029, were reported at zero remaining derivative securities following the transactions.

After all reported transactions, the director's direct beneficial ownership stood at 1,343 ordinary shares, according to the filing. The Form 4 was signed by Meirav Shemesh on behalf of Oppenheimer Israel, as attorney-in-fact, and filed on August 17, 2026.

What Was Disclosed

The filing disclosed two stock option exercises and four share sales by a Camtek Ltd director over August 13-14, 2026, resulting in a direct beneficial ownership of 1,343 ordinary shares and zero remaining options under the reported tranches.